Real-world treatment patterns and early outcomes in advanced intrahepatic cholangiocarcinoma: a descriptive case series
{{output}}
Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, with 70-80% of patients presenting advanced/metastatic disease. Conventional first-line chemotherapies have limitations, and targeted-immunotherapy combinations need real-world validation. This retros... ...
